- STAT+: Popular insulin product enters shortage as other pens leave marketThe Lantus Solostar insulin pen isn't in official FDA shortage, but patients are having a tough time finding it.STAT · 1d ago↗ source
- Senate health panel delays vote on CDC nomineeToo few senators were in attendance to proceed with a vote on the CDC director nominee.STAT · 1d ago↗ source
- Lilly, with new data, to seek FDA approval of obesity drug retatrutide<figure><div><img src="https://imgproxy.divecdn.com/x5fF_ZCHHBjPFAGFuuKXSVkAgBGYTo2hZBIz9OcQdEo/g:ce/rs:fill:1600:900:1/Z3M6Ly9kaXZlc2l0ZS1zdG9yYWdlL2RpdmVpbWFnZS9HZXR0eUltYWdlcy0yMDkyNDczMjEzLmpwZ…BioPharma Dive · 1d ago↗ source